Drug Price Transparency Initiatives and How Payers Should Prepare

Drug Price Transparency Initiatives and How Payers Should Prepare

The focus on lower drug costs has expanded to include providing drug price transparency to physicians and patients. This effort includes a January 2021 Centers for Medicare and Medicaid Services (CMS) requirement for Medicare Part D plans to support Real Time Prescription Benefit (RTPB) information to physicians in their Electronic Health Record (EHR) system.

3 Factors Contributing to Higher Drug Costs Today

3 Factors Contributing to Higher Drug Costs Today

It’s well known that high drug costs prevent many patients from receiving the treatments they need or require patients to sacrifice other necessities to pay for their prescriptions. “Physicians see every day that costs are a major obstacle to our patients getting the right medication at the right time,” said Dr. Jack Resneck, chair of the American Medical Association board of trustees.

The Missing Gap to Drug Savings: Physician Understanding of Formulary and Benefit Information within EHRs

The Missing Gap to Drug Savings: Physician Understanding of Formulary and Benefit Information within EHRs

Equipping EHRs with actionable information and arming physicians with training to find that information are critical for reducing prescription costs for payers and patients.

How Health Benefit Consultants Can Save Employers $88 Per Member Per Year on Prescription Costs

How Health Benefit Consultants Can Save Employers $88 Per Member Per Year on Prescription Costs

Health benefit consultants can help their clients save up to $88 per member per year on prescription spending by sending actionable drug data to doctors. By partnering with BenMedica, consultants can reduce their employers’ and members’ Rx costs, increase medication adherence, and improve patient outcomes.

Achieving Pharmacy Benefit Savings Today Before Real-Time Tools Arrive

Achieving Pharmacy Benefit Savings Today Before Real-Time Tools Arrive

Employers and health plans are missing significant prescription savings opportunities available today through improved formulary and benefit data.  Enhancing patient benefit data leads to better information at the point of prescribing, improves drug cost management, and creates savings now for both payers and patients.

Generating Savings for Patients and Payers through Improved Generic Prescribing

Generating Savings for Patients and Payers through Improved Generic Prescribing

Providing actionable information on generics options to physicians using Formulary and Benefit (F&B) data creates significant savings for payers, employers, and consumers.

Physicians have been conditioned to prescribe generics as part of first-line therapies to save patients money and eliminate callbacks requesting prescription changes. But, not all generic prescribing is equal.

Specialty Medications & Medical Benefit Drugs: The Value of Providing Physicians with Actionable Information at the Point-of-Prescribing

Specialty Medications & Medical Benefit Drugs: The Value of Providing Physicians with Actionable Information at the Point-of-Prescribing

Prescribing cost-effective specialty medications including those covered under a medical benefit requires physicians to have access to drug-specific information on plan coverage and restrictions. Currently, many physicians can only see that a medical benefit drug is not covered as part of the pharmacy benefit with no additional information.

3 Actions Health Plans Can Take Now to Improve Physician Prescribing and Lower Drug Costs

3 Actions Health Plans Can Take Now to Improve Physician Prescribing and Lower Drug Costs

Health plans who do not provide optimal Formulary and Benefit (F&B) information to prescribers through Electronic Health Records (EHRs) are missing a significant opportunity to lower medication costs and increase patient adherence to treatment.